KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Petmed Express (PETS) EPS (Weighted Average and Diluted) (2016 - 2025)

Petmed Express' EPS (Weighted Average and Diluted) history spans 16 years, with the latest figure at -$0.5 for Q4 2025.

  • For Q4 2025, EPS (Weighted Average and Diluted) fell 1566.67% year-over-year to -$0.5; the TTM value through Dec 2025 reached -$3.12, down 31300.0%, while the annual FY2025 figure was -$0.3, 18.92% up from the prior year.
  • EPS (Weighted Average and Diluted) reached -$0.5 in Q4 2025 per PETS's latest filing, down from -$0.41 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.34 in Q1 2021 to a low of -$1.65 in Q2 2025.
  • Average EPS (Weighted Average and Diluted) over 5 years is -$0.08, with a median of $0.01 recorded in 2023.
  • The largest YoY upside for EPS (Weighted Average and Diluted) was 400.0% in 2024 against a maximum downside of 2400.0% in 2024.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at $0.21 in 2021, then tumbled by 104.76% to -$0.01 in 2022, then tumbled by 900.0% to -$0.1 in 2023, then skyrocketed by 70.0% to -$0.03 in 2024, then crashed by 1566.67% to -$0.5 in 2025.
  • Per Business Quant, the three most recent readings for PETS's EPS (Weighted Average and Diluted) are -$0.5 (Q4 2025), -$0.41 (Q3 2025), and -$1.65 (Q2 2025).